Showing results (151-160 of 352) with videos related to
Sort By:
Pageof 36
Pflugers Archiv : European Journal of Physiology|April 30, 2003
Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6Nian-Hang Chen, Maarten E A Reith, Michael W QuickThe Journal of Nursing Administration|March 4, 1998
Work transitionsN Wells, T Barnard, L Mason, et al.Experimental Biology and Medicine (Maywood, N.J.)|December 20, 2017
Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteinsChristian Fercher, Sahar Keshvari, Michael A McGuckin, et al.Journal of Neurocytology|December 1, 1976
Ultrastructrual effects of chemical sympathectomy on brown adipose tissueA Thureson-Klein, B Mill-Hyde, T Barnard, et al.The Journal of Urology|March 1, 1987
Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostatesG Bartsch, F Keen, G Daxenbichler, et al.European Journal of Pharmacology|November 13, 2003
Dopamine transporter as target for drug development of cocaine dependence medicationsAloke K Dutta, Shijun Zhang, Rohit Kolhatkar, et al.Journal of Neuroscience Methods|September 22, 2011
Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusiveJuan Zhen, Solav Ali, Aloke K Dutta, et al.Bioorganic & Medicinal Chemistry Letters|December 21, 2017
Latch and trigger role for R445 in DAT transport explains molecular basis of DTDSMaarten E A Reith, Kymry T Jones, Juan Zhen, et al.Bioorganic & Medicinal Chemistry|November 3, 2004
Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transportersShijun Zhang, Juan Zhen, Maarten E A Reith, et al.Journal of Medicinal Chemistry|February 12, 2010
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's diseaseBalaram Ghosh, Tamara Antonio, Maarten E A Reith, et al.Pageof 36